Skip to content
healthcare.dev

Rhofade

NDC 51862-765, oxymetazoline hydrochloride, cream, from Mayne Pharma.

Product NDC
51862-765
Status
Listed
Labeler
Mayne Pharma
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208552
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51862-765 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYMETAZOLINE HYDROCHLORIDE10 mg/g

Pharmacologic classes

Imidazolines [CS]; Increased Sympathetic Activity [PE]; Vasoconstriction [PE]; Vasoconstrictor [EPC]

Package NDCNDC-11Package
51862-765-005186207650015 TUBE in 1 CARTON (51862-765-00) / 3 g in 1 TUBE
51862-765-30518620765301 TUBE in 1 CARTON (51862-765-30) / 30 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f7dbf12e-a802-4261-bae2-c20977698933
  • NADAC price for package 51862076530

    GET /v1/drugs/nadac/51862076530

Use it

Look up 51862-765 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51862-765 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51862-765. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.